Blog

Here’s Why Facebook Stock Is a Buy and Hold for the Next Decade

Facebook (NASDAQ: FB) is experiencing rapid growth, sometimes at the expense of user privacy. Governments and regulators are taking notice and taking action, imposing fines, and mandating

TheMotleyFool

0

The 3 Most Important Things to Know About Illumina's Q4 Results

A few days ago, I predicted that there would be few if any surprises with Illumina's (NASDAQ: ILMN) fourth-quarter results. This was an easy prediction to make: Illumina CEO Francis deSouza's

TheMotleyFool

0

Kratos' Gremlins Take to the Sky

Gremlins, a futuristic Pentagon program trying to develop a flying aircraft carrier able to launch and recover drones mid-flight, achieved a key development milestone earlier this month. We're a

TheMotleyFool

0

What's Behind Varian Medical Systems' Mixed Q1 Results?

Varian Medical Systems (NYSE: VAR) has been on a roll over the last five months, with its shares soaring 36%. The medical device maker's solid fiscal 2019 fourth-quarter results in October helped

TheMotleyFool

0

7 Mind-Blowing Metrics From Apple's Killer Quarter

Apple (NASDAQ: AAPL) reported its first-quarter results after the market close on Tuesday, and the company didn't disappoint, reporting record-breaking results across numerous product categories

TheMotleyFool

0

The Biggest Risk to Warren Buffett's Portfolio

Few things have stood the test of time as well as Warren Buffett's investing prowess. Beginning with around $10,000 in seed capital in the mid-1950s, Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B)

TheMotleyFool

0

Microsoft Stock Surges To a New All-Time High As Cloud Growth Accelerates

Expectations were high going into Microsoft's (NASDAQ: MSFT) earnings report on Wednesday. The stock gained more than 55% last year on the strength of its cloud services, pushing Microsoft's market

TheMotleyFool

0

Tesla's Blowout Q4 Results Highlight Accelerated Pace of Execution

Shares of Tesla (NASDAQ: TSLA) jumped more than 10% in after-hours trading on Wednesday, following the electric-car maker's fourth-quarter earnings report. Fueled by record vehicle deliveries, Tesla

TheMotleyFool

0

It's Easy to Make This Social Security Mistake -- but Here's How You Can Avoid It

Seniors who are eligible for Social Security benefits can claim them starting at age 62. But your full monthly benefit based on your earnings history isn't yours until you reach full retirement age

TheMotleyFool

0

Allegiant Travel (ALGT) Q4 2019 Earnings Call Transcript

Image source: The Motley Fool.

Allegiant Travel (NASDAQ: ALGT)Q4 2019 Earnings CallJan 29, 2020, 4:30 p.m. ET

Operator

Source Fool.com

TheMotleyFool

0

Service Now (NOW) Q4 2019 Earnings Call Transcript

Image source: The Motley Fool.

Service Now (NYSE: NOW)Q4 2019 Earnings CallJan 29, 2020, 5:00 p.m. ET

Operator

Source Fool.com

TheMotleyFool

0

Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences

Investing in biotech stocks might just be a great idea. The industry as a whole -- as measured by the SPDR S&P Biotech ETF Index -- provided a return of 45.5% over the past three years, narrowly

TheMotleyFool

0

Is Acreage Holdings Stock a Buy?

Back in April 2019, Canopy Growth (NYSE: CGC) reached an agreement to acquire Acreage Holdings (OTC: ACRGF) for $3.4 billion. However, this deal came with a major caveat: The transaction will take

TheMotleyFool

0

Why Victoria's Secret Will Continue to Be a Drag on L Brands

It's no secret that Victoria's Secret has been the reason for L Brands' (NYSE: LB) earnings woes. The company's once-adored lingerie brand has seen revenue dwindle as shoppers turn to rivals that

TheMotleyFool

0

Target and TJX Companies to Benefit From Pier 1's Closures

Pier 1 Imports (NYSE: PIR), known for its eclectic range of home furnishings and decorative items, recently announced the closure of 450 of its stores in order to right-size its business in the face

TheMotleyFool

0

This Oil Stock Expects Its Fast-Paced Growth to Continue in 2020

Hess (NYSE: HES) capped an excellent year by posting solid fourth-quarter results. While the oil producer didn't return to profitability during the period, it turned a key corner as its partner Exxo

TheMotleyFool

0

Is Aurinia Pharmaceuticals Stock a Buy?

Aurinia Pharmaceuticals (NASDAQ: AUPH) has a big year ahead. The Canadian biopharmaceutical company plans on submitting a New Drug Application for what could become its first marketed drug to the

TheMotleyFool

0